NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
October 31, 2006 • Volume 3 / Number 42 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

The information and links on this page are no longer being updated and are provided for reference purposes only.

Featured Article

Lung Cancer Screening Study Spurs Optimism, Caution

New results from a large, observational study suggest that using spiral computed tomography (CT) to screen people at increased risk for lung cancer can detect the disease at an early stage and may increase the number of people who can be cured. Currently, the vast majority of lung cancer diagnoses aren't made until the disease is well advanced, and most of these patients die within 5 years.

Among participants in the study who received a diagnosis of lung cancer based on spiral CT screening and a resulting biopsy, 85 percent had stage I lung cancer (412 of 484), and a statistically estimated 10-year survival among these patients was 88 percent. Among stage I patients who underwent surgery within 1 month of diagnosis, the estimated 10-year survival rate was 92 percent. Very few patients in the study, however, have been followed for 10 years. Read more  

Director's Update

Help Choose the Next Roadmap Initiatives

I'd like to draw the entire cancer community's attention to a Request for Information (RFI) in the October 20 issue of NIH Guide to Grants and Contracts. This important new RFI is soliciting suggestions for new initiatives that will improve and accelerate biomedical and behavioral research and its impact on public health, to be implemented under the aegis of the NIH Roadmap for Medical Research.

The feedback generated will build the foundation from which five to eight new Roadmap initiatives will be launched, from within the currently projected Roadmap budget, beginning in Fiscal Year 2008.  Read more  

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at